User Tools

Site Tools


oa_db:covid19_case_reports_abstracts_pg9

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

oa_db:covid19_case_reports_abstracts_pg9 [2020/06/28 05:24] (current)
bpwhite created
Line 1: Line 1:
 +===== COVID-19 Case Reports Abstracts - Page 9 =====
  
 +[[oa_db:​covid19_case_reports_abstracts|Back to Table of Contents]]
 +
 +[[oa_db:​covid19_case_reports_abstracts_pg8|Page 8]] | [[oa_db:​covid19_case_reports_abstracts_pg10|Page 10]]
 +
 +<​html>​
 +
 +----------------------------------------------------------------------<​br>​
 +<​b>​[473] Title: </​b>​Positive detection of SARS-CoV-2 combined HSV1 and HHV6B virus nucleic acid in tear and conjunctival secretions of a non-conjunctivitis COVID-19 patient with obstruction of common lacrimal duct.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-14<​br>​
 +<​b>​Publisher:​ </​b>​Acta Ophthalmologica (1755375X)<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, <br>
 +<​b>​DOI:​ </​b><​a href="​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1111/​aos.14456">​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1111/​aos.14456</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +BACKGROUND: The current outbreak of COVID-19 has spread rapidly all over the world. Respiratory droplets and contaction with infected patients are the two major transmission routes. However, the value of tear virus nucleic acid is still not clear. We dynamic detected the SARS-CoV-2 in eye sample of one COVID-19 patient with obstruction of common lacrimal ducts. METHODS: Besides the routine examination,​ nasopharyngeal and eye swab were continuously measured by polymerase chain reaction assay and next-generation sequencing (NGS). Gene detection was performed for drug use guidance, and flow cytometry was performed to analyse the lymphocyte subsets. RESULTS: Nasopharyngeal swabs were positive for 22 days, but eye swabs were still continuously positive for 2 weeks after nasopharyngeal swabs turned negative. The low level of lymphocyte and the high level IL-6 lasted for almost 4 weeks, then became near normal. Next-generation sequencing (NGS) confirmed the existing of SARS-CoV-2, HSV1 and HHV6B virus nucleic acid. The gene detection for drug use guidance showed the genetic locus ABCB1 (3435T>​C) rs1045642 belonged to type CC and it mean the efficiency of lopinavir-ritonavir would be significantly decreased. The flow cytometry of lymphocyte subsets showed PD-1(+) CD95(+) cells was accounting for 94.8% in CD3(+) CD8(+) T subset and for 94.8% in CD3(+) TCRgammadelta(+) T subset. CONCLUSIONS:​ As obstruction of common lacrimal duct, positively detection in one eye for 2 weeks more after nasopharyngeal swab became negative. More eye swabs should be collected from COVID-19 patients, especially from those immunocompromised,​ those with eye symptoms and those had a history of ocular diseases.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[474] Title: </​b>​Use of subcutaneous tocilizumab in patients with COVID-19 pneumonia.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-15<​br>​
 +<​b>​Publisher:​ </​b>​Journal of Medical Virology<​br>​
 +<​b>​Keywords:​ </​b>​Medical Microbiology,​ covid-19, sars-cov-2, pneumonia, subcutaneous,​ tocilizumab,​ Health Sciences, Life Sciences, Medicine, Immunology and Microbiology<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1002/​jmv.26016">​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1002/​jmv.26016</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +Over the last months, pandemic SARS-CoV-2 caused a significant challenge for clinicians. Unfortunately,​ no approved and validated treatments are available. Intravenous tocilizumab,​ an antirheumatic drug, seems to be promising in counteracting cytokine storm caused by SARS-CoV-2 infection with associated clinical improvements. We report herein a case series of patients with COVID-19 pneumonia who were treated with tocilizumab administrated,​ for the first time, subcutaneously with good clinical and radiological outcomes. This article is protected by copyright. All rights reserved.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[475] Title: </​b>​The clinical characteristic of eight patients of COVID-19 with positive RT-PCR test after discharge.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-06-02<​br>​
 +<​b>​Publisher:​ </​b>​Journal of Medical Virology<​br>​
 +<​b>​Keywords:​ </​b>​Medical Microbiology,​ corona virus disease 2019, discharge standard, positive rt-pcr, readmission,​ severe acute respiratory syndrome coronavirus-2,​ Health Sciences, Life Sciences, Medicine, Immunology and Microbiology<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1002/​jmv.26017">​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1002/​jmv.26017</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +Corona virus disease 2019 (COVID-19) was caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The phenomenon of positive real time reverse transcription polymerase chain reaction (RT-PCR) result of SARS-CoV-2 in recovered patients had occurred and the research about these patients was rare. In our study, we did a retrospective review of medical records from COVID-19 patients admitted to one ward of Tongji Hospital of Hua Zhong University of Science and Technology from 10 February to 13 April 2020. From 10 February to 13 April 2020, there were 108 patients of COVID-19 admitted in the one ward of Tongji Hospital. Among them, eight cases were readmission patients because the RT-PCR result of SARS-CoV-2 was positive again after discharge. On the second admission, they had no symptoms and their chest computed tomography was almost normal. Data from laboratory tests of the readmission patients showed that all eight patients had normal white blood cell count, lymphocyte count. The inflammatory factors like procalcitonin and interleukin 6 were normal. After treatment, two patients met the standard and were discharged. The other six patients were still in the hospital because their RT-PCR of SARS-CoV-2 did not get three consecutive negative results and the course of two patients had persisted more than 90 days. We still needed to be alert that these patients could infect other people as a source of infection, and we also needed to be alert that these patients become chronic virus carriers. It also aroused our concern about the discharge standard of COVID-19.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[476] Title: </b>A special symptom of olfactory dysfunction in coronavirus disease 2019: report of three cases.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-18<​br>​
 +<​b>​Publisher:​ </​b>​Journal of NeuroVirology<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, covid-19, olfactory dysfunction,​ Health Sciences, Life Sciences, Medicine, Neuroscience,​ Immunology and Microbiology<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​link.springer.com/​article/​10.1007/​s13365-020-00849-w">​https://​link.springer.com/​article/​10.1007/​s13365-020-00849-w</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +Three patients of coronavirus disease (COVID-19) showed the symptoms of olfactory dysfunction. Clinical characteristics and treatment were retrospective analyzed. Olfactory disorders are uncommon symptoms of COVID-19 in China. Early diagnosis and intervention are keys to the recovery of olfactory disorders. Particular attention should be devoted to olfactory dysfunction.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[477] Title: </​b>​Atypical COVID -19 presentation in patient undergoing staged TAAA repair.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-01<​br>​
 +<​b>​Publisher:​ </​b>​Journal of Vascular Surgery Cases and Innovative Techniques<​br>​
 +<​b>​Keywords:​ </b>, <br>
 +<​b>​DOI:​ </​b><​a href="​https://​linkinghub.elsevier.com/​retrieve/​pii/​S2468428720300642">​https://​linkinghub.elsevier.com/​retrieve/​pii/​S2468428720300642</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +This report outlines a case of atypical presentation of Covid 19 viral infection. A 65-year old male was planned for a two staged repair of a Crawford type 3 thoracoabdominal aortic aneurysm. The first stage, TEVAR in descending aorta, was uneventful and patient was discharged on postoperative day 2. He was readmitted 10 days later, presenting with diarrhea, lower limb pain and weakness after 25 meters walking. The patient displayed no fever or upper respiratory tract signs or symptoms. Computer tomography and MR of the spinal cord were normal. Patient was tested positive for Covid 19 virus and later during hospitalization developed more typical fever and respiratory symptoms that were managed medically.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[478] Title: </​b>​COVID-19-associated meningoencephalitis complicated with intracranial hemorrhage: a case report.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-20<​br>​
 +<​b>​Publisher:​ </​b>​Acta Neurochirurgica<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, covid-19, encephalitis,​ ich, meningoencephalitis,​ sdh, Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​link.springer.com/​article/​10.1007/​s00701-020-04402-w">​https://​link.springer.com/​article/​10.1007/​s00701-020-04402-w</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +The coronavirus pandemic that started in December 2019 is mainly related to clinical pictures consistent with respiratory symptoms; nevertheless,​ reports about neurological complications have recently appeared in the medical literature. We describe a case of a 36-year-old coronavirus-positive patient that was admitted on emergency basis; his clinical presentation included neurological symptoms such as drowsiness and mild confusion. Imaging revealed findings consistent with meningoencephalitis complicated by intracerebral hematoma and subdural hematoma. The latter was surgically evacuated after it became chronic and evidence of coronavirus was found in the fluid. Our experience confirms that neurological complications might be a likely event in COVID-19. Although uncommon, the possible occurrence of meningoencephalitis should be kept in mind by physicians involved in the management of COVID-19 patients. Early recognition of brain involvement may provide better prognosis, preventing evolution into intracerebral hemorrhagic events.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[479] Title: </​b>​Acute Type A Aortic Dissection Complicated by COVID-19 Infection.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-01<​br>​
 +<​b>​Publisher:​ </​b>​The Annals of Thoracic Surgery<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, , Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​linkinghub.elsevier.com/​retrieve/​pii/​S0003497520307062">​https://​linkinghub.elsevier.com/​retrieve/​pii/​S0003497520307062</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +A patient underwent surgery for acute type A aortic dissection. SARS- CoV-2 was positive. The postoperative course was complicated by a mixed viral/​bacterial pneumonia with bilateral infiltration,​ treated with antibiotics and hydroxychloroquine,​ without any need for reintubation. The patient recovered and finally could be dismissed. This report shows feasibility for surgical treatment of acute aortic disease in patients with COVID-19.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[480] Title: </​b>​Herpes zoster might be an indicator for latent COVID 19 infection.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-06-11<​br>​
 +<​b>​Publisher:​ </​b>​Dermatologic Therapy<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, covid19, herpes zoster, sars cov2, immune suppression,​ skin rash, Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1111/​dth.13666">​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1111/​dth.13666</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +Various cutaneous manifestations have been observed in patients with COVID-19 infection. Herpes zoster is a viral skin disease caused by varicella zoster that remains dormant in the dorsal root ganglia of cutaneous nerves following a primary chicken pox infection. In this report, we describe two cases COVID infection who first presented with herpes zoster. We are here by suggesting that the clinical presentation of HZ at the time of the current pandemic even in patients giving mild or no suggestive history of upper respiratory symptoms should be considered as an alarming sign for a recent subclinical SARS CoV2 infection.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[481] Title: </​b>​COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-24<​br>​
 +<​b>​Publisher:​ </​b>​European Journal of Neurology<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, covid-19, co-infection,​ herpes zoster, trigeminal, Health Sciences, Life Sciences, Medicine, Neuroscience<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1111/​ene.14361">​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1111/​ene.14361</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +BACKGROUND: Varicella-zoster virus (VZV) is a human neurotropic virus that remains in a latent state within ganglionic neurons throughout the entire neuroaxis after the primary infection. Whenever herpes zoster leads to trigeminal involvement,​ the ophthalmic division is the most implicated. COVID-19 emerged as a viral cause of severe acute respiratory syndrome that spread all over the world in the last months. Co-infection with COVID and other viruses has been registered, but sparsely and embracing the respiratory ones. METHODS: report a case of a co-infection of COVID-19 with VZV, and review the literature. RESULTS: 39-year-old immunocompetent man with oligosymptomatic infection by COVID-19 evolved to left facial herpes zoster affecting the three divisions of trigeminal nerve. The co-infection was remotely registered with other respiratory virus, being influenza the most mentioned. However, the present case is associated to the emergence of a latent virus infection, which might be related to the viral inflammatory response, especially ascending from the nasal cavity, where trigeminal branches are also placed. CONCLUSIONS:​ The emergence of the latent infection by VZV under a rare presentation might illustrate the impact at least locally of COVID-19, once retrograde reactivation of VZV was possibly induced in a young immunocompetent patient.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[482] Title: </​b>​Renal Infarct in a COVID-19 Positive Kidney-Pancreas Transplant Recipient.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-06-24<​br>​
 +<​b>​Publisher:​ </​b>​American Journal of Transplantation<​br>​
 +<​b>​Keywords:​ </​b>​Medical And Health Sciences, , Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1111/​ajt.16089">​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1111/​ajt.16089</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +The novel coronavirus disease 2019 (COVID-19) is associated with increased risk of thromboembolic events, but the extent and duration of this hypercoagulable state remains unknown. We describe the first case report of renal allograft infarction in a 46-year-old kidney-pancreas transplant recipient with no prior history of thromboembolism,​ who presented 26 days after diagnosis of COVID-19. At the time of renal infarct, he was COVID-19 symptom free and repeat test for SARS-CoV-2 was negative. This case report suggests that a hypercoagulable state may persist even after resolution of COVID-19. Further studies are required to determine thromboprophylaxis indications and duration in solid organ transplant recipients with COVID-19.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[483] Title: </​b>​First Case of Focal Epilepsy Associated with SARS-Coronavirus-2.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-06-24<​br>​
 +<​b>​Publisher:​ </​b>​Journal of Medical Virology<​br>​
 +<​b>​Keywords:​ </​b>​Medical Microbiology,​ coronavirus - infection - covid-19 - epilepsy - outbreak - case report - pandemic, Health Sciences, Life Sciences, Medicine, Immunology and Microbiology<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1002/​jmv.26113">​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1002/​jmv.26113</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +A healthy patient presented to Klinikum Altmuhlfranken Weissenburg Hospital, Germany, with two-morning attacks of painful muscle spasm in left upper and lower limbs, without altered consciousness. Full examinations,​ radiological imaging, electroencephalography,​ lumbar puncture, and autoimmune profile were either normal or not consistent. Subsequent epileptic episodes were observed on admission day and following days; thus, the patient was diagnosed with focal epilepsy. The patient started to develop a fever and severe cough at day 4, and SARS-Coronavirus-2 was confirmed through a nasopharyngeal swap. She received anticonvulsants and symptomatic treatments and completely recovered. This report emphasizes on potential nervous system involvement in SARS-Coronavirus-2 pathogenesis. This article is protected by copyright. All rights reserved.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[484] Title: </​b>​[Pathological changes of fatal coronavirus disease 2019 (COVID-19) in the lungs: report of 10 cases by postmortem needle autopsy].<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-06-08<​br>​
 +<​b>​Publisher:​ </​b>​Zhonghua bing li xue za zhi Chinese journal of pathology<​br>​
 +<​b>​Keywords:​ </b>, autopsy, coronavirus infections, lung diseases, lung injury, minimally invasive autopsy, pathological conditions, anatomical, Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​http://​journal.yiigle.com/​PartnerAdmin/​HttpError/​NotFound">​http://​journal.yiigle.com/​PartnerAdmin/​HttpError/​NotFound</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +Objectives: To observe the pulmonary changes with coronavirus disease 2019 (COVID-19) in postmortem needle specimens, to detect the presence of 2019 novel coronavirus(2019-nCoV) in the lung tissues, and to analyze the clinicopathological characteristics. Methods: For 10 decedents with 2019-nCoV infection in Wuhan, bilateral lungs underwent ultrasound-guided percutaneous multi-point puncture autopsy, and pulmonary pathological changes were described in routine hematoxylin-eosin staining (HE) slides. Electron microscopy was also performed. The reverse transcription polymerase chain reaction (RT-PCR) was employed to detect 2019-nCoV nucleic acid in lung tissue, and the pathological characteristics were demonstrated in combination with clinical data analysis. Results: Of the 10 deaths associated with COVID-19, 7 were male and 3 were female. The average age was 70 (39-87) years. Medical record showed that 7 patients had underlying diseases. The average course of disease was 30 (16-36) days. Nine cases showed fibrinous and suppurative exudation in the alveolar cavity accompanied by the formation of hyaline membrane, and fibroblastic proliferation of alveolar septum. Type alveolar epithelial cells showed reactive hyperplasia and desquamation. Many macrophages accumulated in the alveolar cavity. Capillary hyaline thrombus and intravascular mixed thrombus were noted. In some cases, acute bronchiolitis with mucous membrane exfoliation,​ accumulation of bronchiolar secretions, and bronchiolar epithelial metaplasia occurred. In the cohort, a large number of bacteria (cocci) were detected in 1 case and a large number of fungi (yeast type) were detected in 1 case. Nine cases were positive for the nucleic acids of 2019-nCoV while one case remained negative by RT-PCR. Coronavirus particles were detected in the cytoplasm of type alveolar epithelium. Conclusions:​ The pulmonary pathological changes of fatal COVID-19 are diffuse alveolar damage (DAD), mainly in the acute exudative stage and the organic proliferative stage. There are fibrinous exudate aggregation in alveolar cavity with hyaline membrane formation, fibroblastic proliferation in alveolar septum, and alveolar epithelial cell injuries with reactive hyperplasia and desquamation of type alveolar epithelial cells. A large amount of neutrophils and monocytes infiltration is present in most cases and bacteria and fungi are detected in some cases, suggesting a serious bacterial or fungal infection secondary to the DAD.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[485] Title: </​b>​Clinical characteristics and therapeutic procedure for a critical case of novel coronavirus pneumonia treated with glucocorticoids and non-invasive ventilator treatment.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-01-01<​br>​
 +<​b>​Publisher:​ </​b>​Revista da Sociedade Brasileira de Medicina Tropical<​br>​
 +<​b>​Keywords:​ </b>, <br>
 +<​b>​DOI:​ </​b><​a href="​https://​www.scielo.br/​scielo.php?​script=sci_arttext&​pid=S0037-86822020000100711&​tlng=en">​https://​www.scielo.br/​scielo.php?​script=sci_arttext&​pid=S0037-86822020000100711&​tlng=en</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +The novel coronavirus pneumonia (NCP) outbreak occurred in Wuhan, China at the end of 2019. Here, we report the clinical characteristics and therapeutic procedure for a case of severe NCP. The patient was started on glucocorticoids and non-invasive ventilator treatment. After treatment, the patient'​s symptoms improved, and the status was confirmed as NCP negative. Our results may provide clues for the treatment of NCP.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[486] Title: </​b>​COVID-19 presenting with immune thrombocytopenia:​ a case report and review of the literature.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-06-04<​br>​
 +<​b>​Publisher:​ </​b>​Journal of Medical Virology<​br>​
 +<​b>​Keywords:​ </​b>​Medical Microbiology,​ covid-19, itp, sars-cov-2, coronavirus,​ thrombocytopenia,​ Health Sciences, Life Sciences, Medicine, Immunology and Microbiology<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1002/​jmv.26138">​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1002/​jmv.26138</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +Novel coronavirus disease (COVID-19) may be associated with thrombocytopenia which might have different mechanisms in different patients and in different phases of the disease. Cytokine release, thrombotic consumption or autoimmune destruction are some leading etiologies of thrombocytopenia in COVID-19. This case report presents a 41-year-old male COVID-19 patient who had petechiae and purpura as the referral symptoms. Laboratory tests revealed isolated thrombocytopenia with no other additional pathologic findings. Most probable diagnosis was COVID-19 induced immune thrombocytopenia (ITP) and high dose intravenous immunoglobulin (IVIg) treatment generated a good response. There were four other recent publications with a total of eight cases in the literature. The presented case was discussed in comparison with those similar cases. This article is protected by copyright. All rights reserved.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[487] Title: </​b>​Necrotizing periodontal disease: oral manifestation of COVID-19.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-06-22<​br>​
 +<​b>​Publisher:​ </​b>​Oral Diseases<​br>​
 +<​b>​Keywords:​ </​b>​Dentistry,​ covid-19, bacterial co-infection,​ coronavirus disease 2019, necrotizing periodontal disease, Medicine, Dentistry, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1111/​odi.13462">​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1111/​odi.13462</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +We read with interest the series of cases reported by Martin Carreras-Presas et al. (2020). We believe that the described oral vesiculobullous manifestations were suggestive of coronavirus disease 2019 (COVID-19) co-infections,​ which at present, are overlooked and poorly understood (Cox et al., 2020). Increased disease severity and mortality amongst individuals with respiratory viral infections are often attributed to subsequent bacterial co-infections,​ accounting for approximately 95% of deaths during the 1918 Spanish flu pandemic (Morens et al., 2008).<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[488] Title: </​b>​Abdominal pain in a patient with COVID-19 infection: A case of multiple thromboemboli.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-01<​br>​
 +<​b>​Publisher:​ </​b>​American Journal of Emergency Medicine<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, , Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​linkinghub.elsevier.com/​retrieve/​pii/​S0735675720303910">​https://​linkinghub.elsevier.com/​retrieve/​pii/​S0735675720303910</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +The novel coronavirus SARS-CoV-2 (COVID-19) pandemic has created diagnostic uncertainty with regards to distinguishing this infection from pulmonary embolism (PE). Although there appears to be an increased incidence of thromboembolic disease in patients with COVID-19 infection, recommendations regarding anticoagulation are lacking. We present the case of a 61-year-old woman with clinically significant venous and arterial thromboemboli in the setting of COVID-19 infection requiring tissue plasminogen activator (tPA).<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[489] Title: </​b>​Coronavirus disease 2019 (COVID-19) pneumonia incidentally detected on coronary CT angiogram: a do-not-miss diagnosis.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-06-09<​br>​
 +<​b>​Publisher:​ </​b>​Emergency Radiology<​br>​
 +<​b>​Keywords:​ </​b>​Emergency Medicine, atherosclerosis,​ covid-19, ct angiography,​ coronary, coronavirus,​ novel covid-19-infected pneumonia, pneumonia, Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​link.springer.com/​article/​10.1007/​s10140-020-01802-4">​https://​link.springer.com/​article/​10.1007/​s10140-020-01802-4</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +Coronary CT angiograms are commonly performed for the evaluation of coronary artery disease and coronary arterial anatomy. However, extracardiac findings are frequently detected on these examinations and often can explain patients'​ underlying symptoms, having a significant impact on patient management. Here in, we discuss three cases of incidentally detected novel COVID-19-infected pneumonia (NCIP). This case series highlights the image findings in NCIP and emphasizes the importance of evaluating all organs in the field of view on coronary CT angiograms. In addition, with the ongoing outbreak of COVID-19 and exponentially increasing incidence throughout the world, this report stresses the need for including NCIP in the differential diagnosis of patients with typical image findings in at-risk populations,​ as early diagnosis is crucial for appropriate patient management and post-exposure recommendations.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[490] Title: </​b>​Acute hemorrhage after intra-cerebral biopsy in COVID-19 patients: a report of 3 cases.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-06-01<​br>​
 +<​b>​Publisher:​ </​b>​World Neurosurgery<​br>​
 +<​b>​Keywords:​ </b>, covid-19, case report, intra-cerebral biopsy, intra-parenchymal hemorrhage<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​linkinghub.elsevier.com/​retrieve/​pii/​S1878875020312742">​https://​linkinghub.elsevier.com/​retrieve/​pii/​S1878875020312742</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +BACKGROUND: When Belgium'​s COVID-19 outbreak began in March of 2020, our neurosurgical department followed the protocol of most surgical departments in the world and postponed elective surgery. However, patients with tumor-like brain lesions requiring urgent surgery still received treatment as usual, in order to ensure ongoing neuro-oncological care. From a series of 31 patients admitted for brain surgery, three were confirmed as infected by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). CASE DESCRIPTION:​ We present the clinical outcomes of these three COVID-19 patients, who underwent an intra-cerebral biopsy in our department during April of 2020. All suffered from a diffuse intra-parenchymal hemorrhage post-operatively. Unfortunately,​ we were not able to identify a clear etiology of these post-operative complications. It could be hypothesized that an active COVID-19 infection status may be related to a higher bleeding risk. The remaining 28 neuro-oncological non-COVID patients underwent uneventful surgery during the same period. CONCLUSIONS:​ This case series reports the previously unreported and unexpected outcomes of COVID-19 patients suffering from acute hemorrhage after intra-cerebral biopsy procedures. Although no direct relation can yet be established,​ we recommend the neurosurgical community be cautious in such cases.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[491] Title: </​b>​Pulmonary embolism: A complication of COVID 19 infection.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-09-01<​br>​
 +<​b>​Publisher:​ </​b>​Thrombosis Research<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, anticoagulation,​ covid 19, pulmonary embolism, thrombolysis,​ Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​linkinghub.elsevier.com/​retrieve/​pii/​S004938482030205X">​https://​linkinghub.elsevier.com/​retrieve/​pii/​S004938482030205X</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +The Coronavirus Disease 2019 (COVID 19) has been reported in almost every country in the world. Although a large proportion of infected individuals develop only mild symptoms or are asymptomatic,​ the spectrum of the disease among others has been widely variable in severity. Additionally,​ many infected individuals were found to have coagulation markers abnormalities. This is especially true among those progressing to severe pneumonia and multi-organ failure. While the incidence of venous thromboembolic (VTE) disease has been recently noted to be elevated among critically ill patients, the incidence among ambulatory and non-critically ill patients is not yet clearly defined. Herein, we present six patients who didn't have any hypercoagulable risk factors yet presented with pulmonary embolism in association with COVID 19 infection. Furthermore,​ we discuss the possible underlying mechanisms of hypercoagulability and highlight the possibility of underdiagnosing pulmonary embolism in the setting of overlapping symptoms, decreased utilization of imaging secondary to associated risks, and increased turnover times. In addition, we emphasize the role of extended thromboprophylaxis in discharged patients.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[492] Title: </​b>​COVID-19 in 3 people living with HIV in the United Kingdom.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-06-15<​br>​
 +<​b>​Publisher:​ </​b>​Journal of Medical Virology<​br>​
 +<​b>​Keywords:​ </​b>​Medical Microbiology,​ covid-19, hiv, plwh, antiretroviral therapy, morbidity, mortality, Health Sciences, Life Sciences, Medicine, Immunology and Microbiology<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1002/​jmv.26178">​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1002/​jmv.26178</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +We would like to report the clinical characteristics of 3 people living with HIV (PLWH) in the United Kingdom within the context of coronavirus disease 2019 (COVID-19). Our institution serves a population of 500,000 with a prevalence of HIV at 0.34%. At of the time of writing, 5(th) June 2020, only 3 PLWH tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on nasopharyngeal swab specimen using Real-Time Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) have required admission to hospital. This article is protected by copyright. All rights reserved.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[493] Title: </​b>​Confirmed Coronavirus Disease-19 (COVID-19) in a Male with Chronic Myeloid Leukemia Complicated by Febrile Neutropenia and Acute Respiratory Distress Syndrome.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-19<​br>​
 +<​b>​Publisher:​ </​b>​Case Reports in Oncology<​br>​
 +<​b>​Keywords:​ </b>, acute respiratory distress syndrome, covid-19, chronic myelogenous leukemia, febrile neutropenia,​ pneumonia<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​www.karger.com/​Article/​FullText/​508378">​https://​www.karger.com/​Article/​FullText/​508378</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +Coronavirus disease-19 is a respiratory viral disease that commonly presents with mild symptoms. However, it can cause serious complications such as acute respiratory disease, especially in patients with comorbidities. As it is a new disease, the full picture of the disease and its complications are not yet fully understood. Moreover, the patients at risk of complications are not well identified; and the data about the risk in patients with hematological malignancies is limited. Here, we report a 65-year-old male with accelerated phase chronic myeloid leukemia, on dasatinib, tested positive for coronavirus disease-19, then complicated with febrile neutropenia acute respiratory distress syndrome.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[494] Title: </​b>​ACUTE AORTIC DISSECTION SURGERY IN PATIENT WITH COVID-19.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-06-01<​br>​
 +<​b>​Publisher:​ </​b>​The Annals of Thoracic Surgery<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, , Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​linkinghub.elsevier.com/​retrieve/​pii/​S0003497520309413">​https://​linkinghub.elsevier.com/​retrieve/​pii/​S0003497520309413</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +Acute aortic dissection is one of the most common life-threatening disease which affects aortic vessel. We present a case of acute Stanford type A aortic dissection in a patient with covid-19 under treatment of ACE inhibitors. A 68-year-old female complaining of acute chest pain and dyspnea admitted to the emergency clinic of our hospital on May 6, 2020. She had history of diabetes and hypertension. This is one of the first acute aortic surgery case among patients with COVID-19.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[495] Title: </​b>​First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-06-20<​br>​
 +<​b>​Publisher:​ </​b>​Journal of Neurology<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, covid-19, cerebrospinal fluid, clinically isolated syndrome, sars-cov-2, Health Sciences, Life Sciences, Medicine, Neuroscience<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​link.springer.com/​article/​10.1007/​s00415-020-09996-w">​https://​link.springer.com/​article/​10.1007/​s00415-020-09996-w</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +The association between coronaviruses and central nervous system (CNS) demyelinating lesions has been previously shown. However, no case has been described of an association between the novel coronavirus (SARS-COV-2) and CNS demyelinating disease so far. SARS-COV-2 was previously detected in cerebrospinal fluid (CSF) sample of a patient with encephalitis. However, the virus identity was not confirmed by deep sequencing of SARS-COV-2 detected in the CSF. Here, we report a case of a patient with mild respiratory symptoms and neurological manifestations compatible with clinically isolated syndrome. The viral genome of SARS-COV-2 was detected and sequenced in CSF with 99.74-100% similarity between the patient virus and worldwide sequences. This report suggests a possible association of SARS-COV-2 infection with neurological symptoms of demyelinating disease, even in the absence of relevant upper respiratory tract infection signs.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[496] Title: </​b>​Suspected case of COVID-19-associated pancreatitis in a child.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​1<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-08-01<​br>​
 +<​b>​Publisher:​ </​b>​Radiology Case Reports<​br>​
 +<​b>​Keywords:​ </b>, acute pancreatitis,​ covid-19, pediatrics, sars cov-2<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​linkinghub.elsevier.com/​retrieve/​pii/​S1930043320302569">​https://​linkinghub.elsevier.com/​retrieve/​pii/​S1930043320302569</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +The world has been challenged by SARS CoV-2, a new virus causing pneumonia and acute respiratory distress syndrome, with common symptoms of COVID-19 in pediatric patients including both respiratory and GI symptoms. There is a lack of literature implicating COVID-19 in pancreatitis,​ yet viruses are generally understood to be a cause of pancreatitis in children. We present a case of a previously well 7-year-old girl, who presented to the emergency department with a chief complaint of abdominal pain and anorexia. She was diagnosed with acute pancreatitis with an abnormal lipase, ultrasound, and computed tomography, and was found to be COVID-19 positive by polymerase chain reaction. Our case suggests that, in the current pandemic, consideration for SARS CoV-2 testing in children with gastrointestinal symptoms and pancreatitis may be considered. Additionally,​ this case highlights the need for appropriate personal protective equipment for providers, even when COVID is not initially on the differential.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[497] Title: </​b>​Contributory Role of Positron Emission Tomography in a Left Ventricular Assist Device Recipient at the Time of COVID-19 Pandemic.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.75<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-04-16<​br>​
 +<​b>​Publisher:​ </​b>​ASAIO Journal: A Peer-Reviewed Journal of the American Society for Artificial Internal Organs<​br>​
 +<​b>​Keywords:​ </​b>​Biomedical Engineering,​ , Materials Science, Biochemistry,​ Genetics and Molecular Biology, Medicine, Engineering,​ Chemical Engineering,​ Health Sciences, Physical Sciences, Life Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​journals.lww.com/​asaiojournal/​FullText/​2020/​06000/​Contributory_Role_of_Positron_Emission_Tomography.3.aspx">​https://​journals.lww.com/​asaiojournal/​FullText/​2020/​06000/​Contributory_Role_of_Positron_Emission_Tomography.3.aspx</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +In this study, We report on the use of fluorine 18-fluorodeoxyglucose (F-FDG) positron emission tomography (PET) scan examinations for detecting potential COVID-19 respiratory syndrome in asymptomatic left ventricular assist device (LVAD) recipients. Thus, extreme caution and thoughtful approaches should be taken for a timely detection in delicate LVAD populations,​ especially if patients are living in a high-density COVID-19-infected area, and the potential intention for LVAD treatment is bridge to transplantation.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[498] Title: </​b>​Early Leukapheresis Depletion in an Ex-Premature with Severe Acute Respiratory Distress Syndrome Due to Bordetella Pertussis and Coronavirus Infection.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.75<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-04-27<​br>​
 +<​b>​Publisher:​ </​b>​Blood Purification<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, acute respiratory distress syndrome, bordetella pertussis, hyperleukocytosis,​ infant, intensive care, leukapheresis,​ pediatric, pulmonary hypertension,​ Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​www.karger.com/​Article/​Abstract/​507873">​https://​www.karger.com/​Article/​Abstract/​507873</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +We describe a 2 weeks corrected gestational age infant admitted in pediatric intensive care unit (PICU) for severe acute respiratory distress syndrome (ARDS) associated to Bordetella pertussis and Coronavirus infection. He developed leukocytosis as soon as ARDS required intubation and aggressive mechanical ventilation:​ hence he underwent 3 early therapeutic leukapheresis treatments in order to avoid the worsening of related cardiopulmonary complications,​ according to recent literature on pertussis infection in infants. The infant was discharged from PICU healthy.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[499] Title: </​b>​Acute Hyperglycemic Crises with Coronavirus Disease-19: Case Reports.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.75<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-01-01<​br>​
 +<​b>​Publisher:​ </​b>​Diabetes & Metabolism Journal<​br>​
 +<​b>​Keywords:​ </b>, acidosis, covid-19, diabetes complications,​ hyperglycemia,​ ketosis<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​e-dmj.org/​DOIx.php?​id=10.4093/​dmj.2020.0091">​https://​e-dmj.org/​DOIx.php?​id=10.4093/​dmj.2020.0091</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +Since the first case was contracted by coronavirus disease-19 (COVID-19) in Daegu, Korea in February 2020, about 6,800 cases and 130 deaths have been reported on April 9, 2020. Recent studies have reported that patients with diabetes showed higher mortality and they had a worse prognosis than the group without diabetes. In poorly controlled patients with diabetes, acute hyperglycemic crises such as diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS) also might be precipitated by COVID-19. Thus, intensive monitoring and aggressive supportive care should be needed to inadequately controlled patients with diabetes and COVID-19 infection. Here, we report two cases of severe COVID-19 patients with acute hyperglycemic crises in Korea.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[500] Title: </b>A Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.75<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-01<​br>​
 +<​b>​Publisher:​ </​b>​The Pediatric Infectious Disease Journal<​br>​
 +<​b>​Keywords:​ </​b>​Paediatrics And Reproductive Medicine, , Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​journals.lww.com/​pidj/​FullText/​2020/​07000/​A_Case_of_Critically_Ill_Infant_of_Coronavirus.1.aspx">​https://​journals.lww.com/​pidj/​FullText/​2020/​07000/​A_Case_of_Critically_Ill_Infant_of_Coronavirus.1.aspx</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +BACKGROUND: The outbreak of coronavirus disease 2019 (COVID-19) is becoming a global threat. However, our understanding of the clinical characteristics and treatment of critically ill pediatric patients and their ability of transmitting the coronavirus that causes COVID-19 still remains inadequate because only a handful pediatric cases of COVID-19 have been reported. METHODS: Epidemiology,​ clinical characteristics,​ treatment, laboratory data and follow-up information and the treatment of critically ill infant were recorded. RESULTS: The infant had life-threatening clinical features including high fever, septic shock, recurrent apnea, petechiae and acute kidney injury and persistent declined CD3+, CD4+ and CD8+ T cells. The duration of nasopharyngeal virus shedding lasted for 49 days even with the administration of lopinavir/​ritonavir for 8 days. The CD3+, CD4+ and CD8+ T cells was partially recovered 68 days post onset of the disease. Accumulating of effector memory CD4+ T cells (CD4+TEM) was observed among T-cell compartment. The nucleic acid tests and serum antibody for the severe acute respiratory syndrome coronavirus 2 of the infant'​s mother who kept intimate contact with the infant were negative despite no strict personal protection. CONCLUSIONS:​ The persistent reduction of CD4+ and CD8+ T cells was the typical feature of critically ill infant with COVID-19. CD4+ and CD8+ T cells might play a key role in aggravating COVID-19 and predicts a more critical course in children. The prolonged nasopharyngeal virus shedding was related with the severity of respiratory injury. The transmission of SARS-CoV-2 from infant (even very critical cases) to adult might be unlikely.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[501] Title: </​b>​Coronavirus Disease 2019 in Newborns and Very Young Infants: a Series of Six Patients in France.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.75<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-12<​br>​
 +<​b>​Publisher:​ </​b>​The Pediatric Infectious Disease Journal<​br>​
 +<​b>​Keywords:​ </​b>​Paediatrics And Reproductive Medicine, , Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​journals.lww.com/​pidj/​FullText/​2020/​07000/​Coronavirus_Disease_2019_in_Newborns_and_Very.33.aspx">​https://​journals.lww.com/​pidj/​FullText/​2020/​07000/​Coronavirus_Disease_2019_in_Newborns_and_Very.33.aspx</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +We present here a series of 6 infants hospitalized for coronavirus disease 2019 infection from March 14 to March 30, 5 of them are newborns. All 6 patients presented with fever, it was the main symptom for all of them. Only one of them needed oxygen; the others were hospitalized for surveillance but did not need specific care. In our series, coronavirus disease 2019 infection is mostly mild in neonates.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[502] Title: </​b>​Coexistence of COVID-19 and acute ischemic stroke report of four cases.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.75<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-07-01<​br>​
 +<​b>​Publisher:​ </​b>​Journal of Clinical Neuroscience<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, covid-19, coronavirus,​ ischemia, stroke, Health Sciences, Life Sciences, Medicine, Neuroscience<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​linkinghub.elsevier.com/​retrieve/​pii/​S096758682031081X">​https://​linkinghub.elsevier.com/​retrieve/​pii/​S096758682031081X</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +Coronaviruses are revealed to target the human respiratory system mainly. However, they also have neuro-invasive abilities and might spread from the respiratory system to the central nervous system. Herein, we report four patients with COVID-19 simultaneously diagnosed with acute ischemic stroke. There were four stroke cases with simultaneously diagnosis of Covid-19 till the April 14, 2020 in the city of Sakarya, Turkey. They were aged between 45 and 77 years. All four cases were likely to have contracted the virus in Sakarya. The patients had all commonly reported symptoms of Covid-19. Three patients have elevated D-dimer levels, and two of them had high C-reactive protein (CRP) levels. They were managed symptomatically for both the infection and the stroke. Our findings suggest that ischemic cerebrovascular diseases may simultaneously develop in the course of Covid-19 independently of the critical disease process. Increased inflammation predicted by CRP and D-dimer levels may play a role in the formation of ischemia. In particular, elder patients with prothrombotic risk factors should also be considered for the signs of cerebrovascular events in addition to infectious symptoms.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[503] Title: </b>A case series of chest imaging manifestation of COVID-19.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.75<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-01<​br>​
 +<​b>​Publisher:​ </​b>​Radiography (00338281)<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, covid-19, computed tomography (ct), coronavirus,​ chest radiography (cxr), Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​linkinghub.elsevier.com/​retrieve/​pii/​S1078817420300754">​https://​linkinghub.elsevier.com/​retrieve/​pii/​S1078817420300754</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +Coronavirus disease 2019 (COVID-19) is caused by a infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1]. It started in Wuhan, China, in December 2019, after which quickly spread to many other countries around the world. Chest radiography (CXR) and computed tomography (CT) play key roles in managment and diagnosis of COVID-19. In this case series we are presenting three patients with predominant left-sided changes caused by COVID-19 infection.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[504] Title: </​b>​False negative chest X-Rays in patients affected by COVID-19 pneumonia and corresponding chest CT findings.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.75<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-01<​br>​
 +<​b>​Publisher:​ </​b>​Radiography (00338281)<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, covid-19, multidetector computed tomography, pneumonia, radiography,​ severe acute respiratory syndrome coronavirus 2, viral, Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​linkinghub.elsevier.com/​retrieve/​pii/​S1078817420300699">​https://​linkinghub.elsevier.com/​retrieve/​pii/​S1078817420300699</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +Due to the wide availability,​ rapid execution, low cost, and possibility of being acquired at the patient'​s bed, chest X-Ray is a fundamental tool in the diagnosis, follow-up and evaluation of the treatment effectiveness of patients with pneumonia, also in the context of COVID-19 infection. However, false negative cases are possible. We report 4 cases of false negative chest X-Rays, in patients who were diagnosed positive for COVID-19 by real-time transverse-transcript-polymerase chain reaction (RT-PCR), and executed chest unenhanced CTs just after the X-Rays, demonstrating signs of COVID-19 pneumonia.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[505] Title: </​b>​Severe COVID-19 in a pregnant patient admitted to hospital in Wuhan.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.75<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-19<​br>​
 +<​b>​Publisher:​ </​b>​International Journal of Gynecology & Obstetrics<​br>​
 +<​b>​Keywords:​ </​b>​Paediatrics And Reproductive Medicine, covid-19, china, coronavirus,​ pregnancy, sars-cov-2, tracheal intubation, vaginal delivery, Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1002/​ijgo.13232">​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1002/​ijgo.13232</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +In December 2019, an outbreak of a novel coronavirus,​ severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in Wuhan, Hubei Province, China. This virus strain causes the respiratory illness coronavirus disease 2019 (COVID-19). Despite significant research efforts in this field, there is limited data on COVID-19 in pregnancy. This article presents a case of a pregnant woman from Wuhan infected with SARS-CoV-2, including her symptoms, pregnancy outcome, and treatment strategy.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[506] Title: </​b>​FDG PET/CT in a Patient With Mantle Cell Lymphoma and COVID-19: Typical Findings.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.75<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-01<​br>​
 +<​b>​Publisher:​ </​b>​Clinical Nuclear Medicine<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, , Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​journals.lww.com/​nuclearmed/​Abstract/​2020/​07000/​FDG_PET_CT_in_a_Patient_With_Mantle_Cell_Lymphoma.28.aspx">​https://​journals.lww.com/​nuclearmed/​Abstract/​2020/​07000/​FDG_PET_CT_in_a_Patient_With_Mantle_Cell_Lymphoma.28.aspx</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +A 52-year-old woman with no medical history was admitted on March 18, 2020, presenting since 3 days asthenia, abdominal pain, and dry cough but no fever. Adenomegalies,​ splenomegaly,​ leukocytosis,​ and elevated LDH suggested mature lymphoproliferation. Considering the current health context, an RT-PCR testing for COVID-19 (coronavirus disease 2019) was performed and found to be positive. Early chest CT showed no sign of pulmonary infection but multiple adenomegalies. An F-FDG PET/CT performed 5 days later to assess the extent of the hemopathy revealed the apparition of FDG-avid bilateral ground glass and subpleural curvilinear opacities suggesting COVID-19-associated pneumopathy.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[507] Title: </​b>​ORCHIEPIDIDYMITIS IN A BOY WITH COVID-19.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.75<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-26<​br>​
 +<​b>​Publisher:​ </​b>​The Pediatric Infectious Disease Journal<​br>​
 +<​b>​Keywords:​ </​b>​Paediatrics And Reproductive Medicine, , Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​journals.lww.com/​pidj/​Abstract/​9000/​ORCHIEPIDIDYMITIS_IN_A_BOY_WITH_COVID_19.96136.aspx">​https://​journals.lww.com/​pidj/​Abstract/​9000/​ORCHIEPIDIDYMITIS_IN_A_BOY_WITH_COVID_19.96136.aspx</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +Coronavirus disease 2019 (COVID-19) symptoms in children are incompletely described. We present the first case of orchiepididymitis associated with COVID-19 in a boy and discuss pathways of testicular involvement by SARS-CoV2 virus. This case underlines the need for further study of the clinical presentation of pediatric COVID-19 and the potential association with nonrespiratory symptoms.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[508] Title: </b>A 3-month-old child with COVID-19: A case report.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.75<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-06-05<​br>​
 +<​b>​Publisher:​ </​b>​Medicine<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, , Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​journals.lww.com/​md-journal/​FullText/​2020/​06050/​A_3_month_old_child_with_COVID_19__A_case_report.92.aspx">​https://​journals.lww.com/​md-journal/​FullText/​2020/​06050/​A_3_month_old_child_with_COVID_19__A_case_report.92.aspx</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +INTRODUCTION:​ Coronavirus disease 2019 (COVID-19) is pandemic and is a medical issue. However, children account for a small portion of those with the disease, and there are few published reports of COVID-19 in children. The patient reported in this case report is the youngest case reported in Chengdu, China to date. PATIENT CONCERNS: A 3-month-old male infant presented with cough and rhinorrhea. DIAGNOSIS: Family members from Wuhan, the epicenter of the epidemic came to stay in the patient'​s home 16 days before the onset of his disease, and his mother had been diagnosed with COVID-19. He was diagnosed with COVID-19 based on a history of exposure and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),​ detected using reverse transcription polymerase chain reaction (RT-PCR). INTERVENTIONS:​ The patient was admitted to hospital and treated symptomatically with oral medication. OUTCOMES: The patient recovered completely and was discharged after one month of hospitalization. He tested negative for SARS-CoV-2 using RT-PCR and a chest CT performed 4 weeks after admission showed marked improvement prior to discharge. CONCLUSION: Clinicians must be aware of the presentation of COVID-19 in children because it differs from that in adults.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[509] Title: </​b>​ANOSMIA AND AGEUSIA: NOT AN UNCOMMON PRESENTATION OF COVID-19 INFECTION IN CHILDREN AND ADOLESCENTS.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.75<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-06-08<​br>​
 +<​b>​Publisher:​ </​b>​The Pediatric Infectious Disease Journal<​br>​
 +<​b>​Keywords:​ </​b>​Paediatrics And Reproductive Medicine, , Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​journals.lww.com/​pidj/​Abstract/​9000/​ANOSMIA_AND_AGEUSIA__NOT_AN_UNCOMMON_PRESENTATION.96119.aspx">​https://​journals.lww.com/​pidj/​Abstract/​9000/​ANOSMIA_AND_AGEUSIA__NOT_AN_UNCOMMON_PRESENTATION.96119.aspx</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +Since the emergence of a cluster of viral pneumonia cases in Wuhan, Hubei Province, People'​s Republic of China, at the end of December 2019, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2),​ a novel coronavirus also known as "​coronavirus disease 2019 (COVID-19),"​ as of 7 April 2020, more than 1,214,466 cases of COVID-19 have been reported in more than 200 countries and territories,​ resulting in more than 67,767 deaths. The disease was recognized by World Health Organization (WHO) as a pandemic on 11 March 2020. Published reports of adult patients with COVID-19 infection described symptoms including fever, cough, fatigue, sputum production, headache, dyspnoea and diarrhoea. Children usually showed milder respiratory symptoms or were asymptomatic,​ while loss of taste or sensation of smell were seldom reported. In this paper, we report three cases of pediatric patients with COVID-19 infection who presented with anosmia and/or ageusia.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[510] Title: </​b>​COVID-19 presenting as severe, persistent abdominal pain and causing late respiratory compromise in a 33-year-old man.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.75<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-06-16<​br>​
 +<​b>​Publisher:​ </​b>​BMJ Case Reports<​br>​
 +<​b>​Keywords:​ </b>, adult intensive care, infectious diseases, medical management, pneumonia (respiratory medicine), respiratory medicine<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​casereports.bmj.com/​lookup/​doi/​10.1136/​bcr-2020-236030">​https://​casereports.bmj.com/​lookup/​doi/​10.1136/​bcr-2020-236030</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +A 33-year-old man presented repeatedly with severe abdominal pain and diarrhoea. Renal colic was suspected, and he was admitted for pain management. Questioning elicited an additional history of sore throat and mild, dry cough. Inflammatory markers were mildly raised (C reactive protein (CRP) 40 mg/L). Initial nasopharyngeal swabs were negative for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) by PCR. CT of the kidneys, ureters and bladder (CT KUB) was normal; however, CT of the thorax showed multifocal bilateral peripheral areas of consolidation consistent with COVID-19 infection. He developed respiratory compromise and was transferred to the intensive care unit (ICU). Sputum was positive for SARS-CoV-2 by PCR, and culture grew Yersinia enterocolitica He recovered following supportive management and treatment with piperacillin-tazobactam.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[511] Title: </​b>​Bradycardia in Patients With COVID-19: A Calm Before the Storm?<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.75<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-06-13<​br>​
 +<​b>​Publisher:​ </​b>​Cureus<​br>​
 +<​b>​Keywords:​ </b>, arrhythmia, bradycardia,​ cardiovascular,​ corona virus disease, covid-19, cytokine release syndrome (crs), sars-cov-2 (severe acute respiratory syndrome coronavirus -2)<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​www.cureus.com/​articles/​34085-bradycardia-in-patients-with-covid-19-a-calm-before-the-storm">​https://​www.cureus.com/​articles/​34085-bradycardia-in-patients-with-covid-19-a-calm-before-the-storm</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +Cardiac manifestations of coronavirus disease 19 (COVID-19), including arrhythmia, have been described in the literature. However, to our knowledge, association of COVID-19 with bradycardia has not been reported. This case study describes sinus bradycardia as a potential manifestation of COVID-19. This is a retrospective case series of four patients with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, admitted to St. Luke's University Health Network ICU between 24 March 2020 and 5 April 2020. Medical records of these patients were reviewed using the EPIC electronic health record system. Demographic,​ clinical, laboratory, and treatment data were reviewed against periods of bradycardia in each patient. The patient group comprised two males and two females. Two patients had pre-existing cardiovascular (CV) comorbidities but no history of arrythmias. Heart rates ranged between 66 and 88 beats/min on admission. The lowest rates during bradycardia were between 42 and 49 beats/min. The onset of sinus bradycardia in patients 1, 2, and 3 were day nine, 15, and five of illness, respectively. Patient 4 had three episodes of bradycardia,​ starting on day 10 of illness. Patients'​ bradycardia episodes lasted one to 14 days. During bradycardia,​ maximum body temperatures ranged between 99.9 and 100.2 degree Fahrenheit. Patients 2, 3, and 4 required vasopressors to maintain mean arterial pressure > 65 mmHg during episodes. All four patients were on propofol at some point during bradycardia with patients 1, 2, and 3 also receiving dexmedetomidine. There was no consistent correlation of these medications with bradycardia. Electrocardiogram (ECG) findings included sinus bradycardia. Prolonged QTc interval observed in patient 2 on admission improved during bradycardia. Transient sinus bradycardia is a possible manifestation of COVID-19 and is important for close CV surveillance. Etiology can be multifactorial,​ but severe hypoxia, inflammatory damage of cardiac pacemaker cells, and exaggerated response to medications are possible triggers. High levels of pro-inflammatory cytokines may act directly on the sinoatrial (SA) node contributing to the development of bradycardia. This may be a warning sign of the onset of a serious cytokine storm. An increased awareness of possible exaggerated bradycardia response is important to consider with the use of empiric medications which have arrhythmogenic effects.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[512] Title: </​b>​Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.75<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-06-18<​br>​
 +<​b>​Publisher:​ </​b>​Journal of the European Academy of Dermatology & Venereology<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, acro-ischemia,​ covid 19, Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1111/​jdv.16763">​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1111/​jdv.16763</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +A-83-year-old man was admitted on the 3(rd) of April 2020 for respiratory distress. He had presented with fever the 20th of march. On the 2nd of April he had an acute pain of both legs associated with discoloration. He was admitted to the emergency room on the following day. His temperature was 38 degrees C, he was dyspneic despite oxygen. He had bilateral and symmetrical well limited black skin on both legs (Figure).<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[513] Title: </​b>​2019 novel coronavirus (COVID-19) pneumonia complications:​ the importance of lung ultrasound.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.75<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-06-19<​br>​
 +<​b>​Publisher:​ </​b>​Journal of Ultrasound<​br>​
 +<​b>​Keywords:​ </​b>​Medicine & Public Health, covid-19, lung ultrasound, pneumonia, pneumothorax,​ Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​link.springer.com/​article/​10.1007/​s40477-020-00494-3">​https://​link.springer.com/​article/​10.1007/​s40477-020-00494-3</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +In December 2019, a novel coronavirus (SARS-Cov-2) was first reported in Wuhan, China, and rapidly spread around the world, leading to an international emerging public health emergency. As reported from Chinese experiences,​ approximately 20% of patients had a severe course, requiring intensive care, with an overall case fatality rate of 2.3%. In diagnosis, chest computed tomography most commonly showed ground-glass opacity with or without consolidative patterns.Herein,​ we report a case of a patient affected by COVID-19 pneumonia referred in the emergency department of our institution on April 4, 2020, with peculiar lung ultrasound findings.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[514] Title: </​b>​CT image of novel coronavirus pneumonia: a case report.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.5<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-03-18<​br>​
 +<​b>​Publisher:​ </​b>​Japanese Journal of Radiology<​br>​
 +<​b>​Keywords:​ </​b>​Imaging / Radiology, covid-19 pneumonia, ct, ground-glass opacities, Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​link.springer.com/​article/​10.1007/​s11604-020-00945-1">​https://​link.springer.com/​article/​10.1007/​s11604-020-00945-1</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +OBJECTIVE: Knowledge of CT characteristics of COVID-19 pneumonia might be helpful to the early diagnosis and treatment of patients, and to control the spread of infection. METHODS: The chest CT images of the patient were collected to describe the CT manifestations and characteristics,​ and they were compared with the previous studies. RESULTS: Multiple patchy ground-glass opacities (GGOs) were seen in bilateral lung, mostly in subpleural areas. They progressed within 3 days, and nodular GGOs were also seen together with subpleural patchy GGOs. CONCLUSION: Our case of COVID-19 pneumonia showed multiple subpleural GGOs in bilateral lung, rapid progression,​ and it also accompanied nodular GGOs on chest CT. These findings were consistent with the previous reports, and they might be useful for early detection and evaluation of severity of COVID-19 pneumonia.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[515] Title: </​b>​Lung Involvement Found on Chest CT Scan in a Pre-Symptomatic Person with SARS-CoV-2 Infection: A Case Report.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.5<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-04-07<​br>​
 +<​b>​Publisher:​ </​b>​Tropical Medicine and Infectious Disease<​br>​
 +<​b>​Keywords:​ </b>, covid-19, sars-cov-2, emerging infectious diseases, pneumonia<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​www.mdpi.com/​2414-6366/​5/​2/​56">​https://​www.mdpi.com/​2414-6366/​5/​2/​56</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +The novel coronavirus SARS-CoV-2 infection is spreading worldwide, and there are many reports of acute respiratory distress syndrome caused by this infection. However, asymptomatic lung involvement has not been reported. We hereby present the case of a 44-year-old health-care worker, who was found to be infected with the SARS-CoV-2 virus after a CT-scan performed for an unrelated condition revealed a lesion in the lung field compatible with COVID-19 infection. His condition deteriorated initially, but eventually improved with supportive treatment and the compassionate use of antivirals and antimalarials and is now in a stable condition.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[516] Title: </​b>​Vaginal delivery report of a healthy neonate born to a convalescent mother with COVID--19.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.5<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-04-30<​br>​
 +<​b>​Publisher:​ </​b>​Journal of Medical Virology<​br>​
 +<​b>​Keywords:​ </​b>​Medical Microbiology,​ covid-19, delivery, infection, vertical transmission,​ Health Sciences, Life Sciences, Medicine, Immunology and Microbiology<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1002/​jmv.25857">​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1002/​jmv.25857</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +The outbreak of the infection of 2019 novel coronavirus disease (COVID--19) has become a challenging public health threat worldwide. Limited data are available for pregnant women with COVID-19 pneumonia. We report a case of a convalescing pregnant woman diagnosed with COVID-19 infection 37 days before delivery in the third trimester. A live birth without severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was performed successfully via the vagina. The findings from our case indicate that there is no intrauterine transmission in this woman who developed COVID-19 pneumonia in late pregnancy.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[517] Title: </​b>​Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.5<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-06-01<​br>​
 +<​b>​Publisher:​ </​b>​Journal of Clinical Neuroscience<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, acute necrotizing encephalopathy,​ adult onset still'​s disease, diffuse hemorrhagic encephalopathy,​ disseminated intravascular coagulation,​ hemophagocytic syndrome, Health Sciences, Life Sciences, Medicine, Neuroscience<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​linkinghub.elsevier.com/​retrieve/​pii/​S0967586820306810">​https://​linkinghub.elsevier.com/​retrieve/​pii/​S0967586820306810</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +The diagnosis of hemophagocytic lymphohistiocytosis (HLH) with cerebral involvement is challenging given the rarity of HLH and its resemblance to the much more common severe sepsis. Timely diagnosis and treatment may be lifesaving. We report two cases demonstrating different and rare forms of severe brain involvement in adult patients with HLH: acute necrotizing encephalopathy,​ and diffuse hemorrhagic disease due to disseminated intravascular coagulation. Severe HLH with brain involvement in adults is rare. HLH with cerebral involvement should be considered in patients presenting with severe systemic inflammatory response syndrome (SIRS) but negative cultures and unusual or unexpectedly severe clinical and/or radiologic signs of cerebral dysfunction. Similar brain injury may occur in patients with cytokine storm syndrome due to COVID-19. BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) presents with fevers, rash, organomegaly,​ cytopenia, and increased triglycerides and ferritin (Ramos-Casals et al., 2014) [1]. Neurologic abnormalities are reported in about one-third of patients (Cai et al., 2017), including a few cases of acute necrotizing encephalopathy (ANE) (Xiujuan et al., 2015). Coagulation abnormalities are frequent in HLH patients (Valade et al., 2015). OBJECTIVE: To raise awareness about the importance of early diagnosis and treatment of HLH with neurological involvement to prevent serious complications and demise.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[518] Title: </​b>​One case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a low CD4(+) T-cell count.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.5<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-07-01<​br>​
 +<​b>​Publisher:​ </​b>​International Journal of Infectious Diseases<​br>​
 +<​b>​Keywords:​ </​b>​Microbiology,​ antibody, covid-19, hiv, sars-cov-2, Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​linkinghub.elsevier.com/​retrieve/​pii/​S1201971220302769">​https://​linkinghub.elsevier.com/​retrieve/​pii/​S1201971220302769</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +The ongoing outbreak of COVID-19 that began in Wuhan, China, become an emergency of international concern when thousands of people were infected around the world. This study reports a case simultaneously infected by SARS-Cov-2 and HIV, which showed a longer disease course and slower generation of specific antibodies. This case highlights that a co-infection of SARS-Cov-2 and HIV may severely impair the immune system.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[519] Title: </​b>​COVID-19 Presenting with Seizures.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.5<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-01-01<​br>​
 +<​b>​Publisher:​ </​b>​IDCases<​br>​
 +<​b>​Keywords:​ </b>, covid 19, pandemic, sars, sars cov-2, coronavirus,​ novel coronavirus<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​linkinghub.elsevier.com/​retrieve/​pii/​S2214250920300901">​https://​linkinghub.elsevier.com/​retrieve/​pii/​S2214250920300901</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +This case report examines a male with no previous history of seizures initially admitting to the medical service later upgraded to ICU after respiratory failure developing multiple episodes of seizures. Laboratory values on admission, neurological investigations,​ as well as review of current literature on COVID-19 encephalitis is provided.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[520] Title: </​b>​COVID-19 pneumonia in kidney transplant recipients-Where we are?<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.5<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-26<​br>​
 +<​b>​Publisher:​ </​b>​Transplant Infectious Disease<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, covid-19, heparin, hydroxychloroquine and azithromycin,​ infectious diseases, kidney and liver transplantation,​ nonpathogen-specifc immune parameters, Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1111/​tid.13306">​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1111/​tid.13306</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +In late December 2019, China reported cases of respiratory illness in humans that involved a novel coronavirus SARS-CoV-2. On March 20, 2020, the first coronavirus disease 2019 (COVID-19) in Brazil was diagnosed, and by now, we present the report on the first case of COVID among transplant recipients in our country. A liver and kidney transplant patient with SARS-CoV-2 pneumonia without respiratory failure was treated in a clinical multimodal strategy consisting of symptomatic support therapy, immunosuppression reduction, use of anti-coronavirus drugs and heparin leading to a progressive improvement of patient symptoms till discharge. The authors also present a comprehensive review of published cases.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[521] Title: </​b>​First Case of an Infant with COVID-19 in the Middle East.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.5<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-04-03<​br>​
 +<​b>​Publisher:​ </​b>​Cureus<​br>​
 +<​b>​Keywords:​ </b>, children, coronavirus,​ covid-19, gastrointestinal symptoms, infants, lebanon, middle east, pandemic, pediatrics, sars-cov-2<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​www.cureus.com/​articles/​30283-first-case-of-an-infant-with-covid-19-in-the-middle-east">​https://​www.cureus.com/​articles/​30283-first-case-of-an-infant-with-covid-19-in-the-middle-east</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +The novel coronavirus (COVID-19) has been declared a worldwide pandemic. It was initially thought to spare children and adolescents as significantly smaller number of cases have been reported in the pediatric population in comparison to adults. Here, we report the case of a 16-month-old female infant from Lebanon who presented with fever and severe diarrhea and tested positive for COVID-19. Her symptoms started six days prior to presentation with no cough, rhinorrhea, or other respiratory manifestations reported. Chest radiography showed lobar consolidation and bronchial infiltrates. Blood culture was positive for Streptococcus pneumoniae. Stool and urine cultures were negative. She was treated with ceftriaxone and metronidazole. Her RT-PCR test was negative after five days of treatment, suggesting that children can clear the virus faster than adults. The patient likely contracted the virus from her parents, who because of the fear of social stigma hide recent history of respiratory illness. These findings serve as a practical reference for the clinical diagnosis and medical treatment of children with COVID-19.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[522] Title: </​b>​Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.5<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-04-06<​br>​
 +<​b>​Publisher:​ </​b>​Cureus<​br>​
 +<​b>​Keywords:​ </b>, ards, case report, corona virus, covid-19, covid-2019, novel corona virus, rhabdomyolysis<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​www.cureus.com/​articles/​30228-rhabdomyolysis-as-a-presentation-of-2019-novel-coronavirus-disease">​https://​www.cureus.com/​articles/​30228-rhabdomyolysis-as-a-presentation-of-2019-novel-coronavirus-disease</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +An emerging viral infection is a global public health challenge. The development of modern, fast, and extensive transportation makes the outbreak hard to contain. Everyone is at risk, and the outbreak can rapidly turn into a pandemic crisis, like what we are currently facing for the 2019 novel coronavirus disease (COVID-19). Prompt diagnosis of the case is required to improve patients'​ prognosis and control of the outbreak. The common manifestations of COVID-19 include fever, cough, dyspnea, and malaise. However, patients may present with atypical symptoms that pose a diagnostic challenge. We report the first case of an elderly male who presented with rhabdomyolysis and later was diagnosed with COVID-19. Clinicians should be aware that rhabdomyolysis can be an initial presentation of COVID-19 or can occur at any time during the disease course. Patients with rhabdomyolysis should receive aggressive fluid administration to prevent acute kidney injury (AKI). However, COVID-19 patients are at risk of worsening oxygenation and acute hypoxemic respiratory failure from fluid overload. Therefore, cautious fluid administration is needed in COVID-19 patients with rhabdomyolysis.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[523] Title: </​b>​Clinical characteristics of patients with COVID-19 in Japan: a single-center case series.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.5<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-08<​br>​
 +<​b>​Publisher:​ </​b>​Journal of Infectious Diseases<​br>​
 +<​b>​Keywords:​ </​b>​Medical And Health Sciences, covid-19, pcr tests, narrative information,​ Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​http://​doi.org/​10.1093/​infdis/​jiaa244">​http://​doi.org/​10.1093/​infdis/​jiaa244</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +We report a case series of 6 patients with confirmed COVID-19 in Wakayama prefecture, Japan. All 6 of the patients tested positive in pharyngeal swab PCR tests, and 2 of the 6 were still positive at 3 weeks after onset. All of the patients exhibited bilateral ground glass opacities (GGO) on computed tomography (CT). This paper also reports narrative information on the spectrum of symptoms collected directly from the patients. It would be difficult to triage patients with COVID-19 based on the typical symptoms of fever and/or cough, although PCR and CT are definitive in diagnosis.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[524] Title: </​b>​Sudden death due to acute pulmonary embolism in a young woman with COVID-19.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.5<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-11<​br>​
 +<​b>​Publisher:​ </​b>​Journal of Thrombosis and Thrombolysis<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, covid-19, case report, pulmonary embolism, sudden death, Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​link.springer.com/​article/​10.1007/​s11239-020-02132-5">​https://​link.springer.com/​article/​10.1007/​s11239-020-02132-5</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +Coronavirus disease 2019 (COVID-19) is an infectious disease that primarily affects the respiratory system, but it may cause cardiovascular complications such as thromboembolism. Rarely, pulmonary embolism may be encountered in patients with severe COVID-19 infection, especially in intensive care units. An asymptomatic young case of COVID-19 presenting with sudden death due to acute massive pulmonary embolism has not been previously described. We report a 41-year-old woman presented to emergency department with sudden death during physical activity. She had only history of diabetes mellitus and she was asymptomatic until sudden death. CT pulmonary angiography and chest CT scans revealed acute massive embolism and typical imaging findings of COVID-19 pneumonia, respectively. Interestingly,​ the patient had no symptoms or signs of infection and also had no risk factors for thromboembolism. COVID-19 infection appears to induce venous thromboembolism,​ especially pulmonary embolism. The case is remarkable in terms of showing how insidious and life-threatening COVID-19 infection can be.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[525] Title: </​b>​Early Guillain-Barre syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.5<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-12<​br>​
 +<​b>​Publisher:​ </​b>​Neurological Sciences<​br>​
 +<​b>​Keywords:​ </​b>​Medicine & Public Health, coronavirus disease 2019 (covid-19), guillain-barre syndrome, para-infectious guillain-barre syndrome, sars-cov-2 neurological complications,​ Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​link.springer.com/​article/​10.1007/​s10072-020-04449-8">​https://​link.springer.com/​article/​10.1007/​s10072-020-04449-8</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +Guillain-Barre syndrome (GBS) is an acute polyradiculoneuropathy associated with dysimmune processes, often related to a previous infectious exposure. During Italian severe acute respiratory syndrome coronavirus-2 outbreak, a woman presented with a rapidly progressive flaccid paralysis with unilateral facial neuropathy after a few days of mild respiratory symptoms. Coronavirus was detected by nasopharyngeal swab, but there was no evidence of its presence in her cerebrospinal fluid, which confirmed the typical albumin-cytological dissociation of GBS, along with consistent neurophysiological data. Despite immunoglobulin infusions and intensive supportive care, her clinical picture worsened simultaneously both from the respiratory and neurological point of view, as if reflecting different aspects of the same systemic inflammatory response. Similar early complications have already been observed in patients with para-infectious GBS related to Zika virus, but pathological mechanisms have yet to be established.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[526] Title: </​b>​Weakness and elevated creatinine kinase as the initial presentation of coronavirus disease 2019 (COVID-19).<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.5<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-01<​br>​
 +<​b>​Publisher:​ </​b>​American Journal of Emergency Medicine<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, covid-19, elevated creatinine kinase, rhabdomyolysis,​ sars-cov-2, Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​linkinghub.elsevier.com/​retrieve/​pii/​S0735675720303533">​https://​linkinghub.elsevier.com/​retrieve/​pii/​S0735675720303533</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +COVID-19 is a global public health emergency with more than one million positive cases across the globe. COVID-19 has a multifaceted presentation. We are herein to report two cases of SARS-CoV-2 induced rhabdomyolysis with an initial presentation of weakness and elevated creatinine kinase (CK). Both patients had no respiratory symptoms, they only complained of generalized weakness and were found to have elevated CK. Routine chest X-ray showed bilateral infiltrates in both cases and subsequently reverse-transcription polymerase chain reaction (RT-PCR) for SARS-CoV-2 was positive. To the best of our knowledge, there was only one literature to date documented SARS-CoV-2 induced rhabdomyolysis as a late complication of COVID-19 patient. Our cases showed that elevated CK and rhabdomyolysis can be the sole initial presentation of patients with COVID-19 and total CK should be ordered in every patient on admission.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[527] Title: </​b>​Intravenous Thrombolysis for Stroke in a COVID-19 Positive Filipino Patient, a Case Report.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.5<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-07-01<​br>​
 +<​b>​Publisher:​ </​b>​Journal of Clinical Neuroscience<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, covid-19, coronavirus,​ iv-rtpa, sars-cov-2, stroke, Health Sciences, Life Sciences, Medicine, Neuroscience<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​linkinghub.elsevier.com/​retrieve/​pii/​S096758682030727X">​https://​linkinghub.elsevier.com/​retrieve/​pii/​S096758682030727X</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +The 2019 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) which was first reported in Wuhan, China last December 2019, has been declared an emergency by the World Health Organization but eventually progressed to become a Pandemic. To date, Coronavirus Disease 2019 (COVID-19) has affected at least 100,000 individuals worldwide, reaching thousands of mortalities (Zhou et al., 2020; World Health Organization,​ 2020). In the Philippines,​ the number of COVID-19 confirmed positive cases is over 636 and is expected to rise (Department of Health, 2020). Respiratory infections alongside their comorbidities can induce acute myocardial infarction and acute ischemic stroke (Warren-Gash et al., 2018) [3]. These may further bring challenges in the management and administration of Intravenous (IV) Alteplase in eligible patients. Currently, there are no case reports in the administration IV Altepase in ischemic stroke patients who are COVID-19 positive. We present a case of a 62-year old female who was admitted due to cough, colds and shortness of breath of 2 weeks duration and was tested to be COVD-19 positive. She suffered from an ischemic stroke while in the Medical Intensive Care Unit and was given Intravenous thrombolysis.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[528] Title: </​b>​Primary percutaneous coronary intervention in a COVID-19 patient with ST-segment elevation myocardial infarction after lung transplantation:​ a case report.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.5<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-09<​br>​
 +<​b>​Publisher:​ </​b>​Journal of Zhejiang University - Science B<br>
 +<​b>​Keywords:​ </​b>​Biological Sciences, coronavirus disease 2019 (covid-19); lung transplantation;​ st-segment elevation myocardial infarction; percutaneous coronary revascularization,​ Veterinary, Biochemistry,​ Genetics and Molecular Biology, Health Sciences, Life Sciences, Pharmacology,​ Toxicology and Pharmaceutics,​ Medicine<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​link.springer.com/​article/​10.1631/​jzus.B2000182">​https://​link.springer.com/​article/​10.1631/​jzus.B2000182</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +We present an unusual case of a patient with bilateral-lung transplantation due to severe coronavirus disease 2019 (COVID-19), who subsequently suffered complications with acute myocardial infarction and underwent primary percutaneous coronary intervention (PCI).<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[529] Title: </​b>​COVID-19 Presenting with Atypical Sweet'​s Syndrome.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.5<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-26<​br>​
 +<​b>​Publisher:​ </​b>​Journal of the European Academy of Dermatology & Venereology<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, covid-19, sars-cov-2, sweet'​s syndrome, acute febrile neutrophilic dermatosis, Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1111/​jdv.16662">​https://​onlinelibrary.wiley.com/​doi/​abs/​10.1111/​jdv.16662</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +On March 11, 2020, the first case of the novel coronavirus 2019 disease (COVID-19) was officially confirmed in Turkey. The disease continues to spread, and the number of patients has risen to 120,000 by the end of April. In this observation,​ we report an atypical presentation of COVID-19 in a patient with indurated painful nodules. A-61-years-old woman with a one-week history of fever (axillary 38 degrees C) and nodules on the cheek was admitted to the hospital with fatigue, arthralgia and myalgia.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[530] Title: </​b>​COVID-19-Associated Miller Fisher Syndrome: MRI Findings.<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.5<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-28<​br>​
 +<​b>​Publisher:​ </​b>​American Journal of Neuroradiology<​br>​
 +<​b>​Keywords:​ </​b>​Clinical Sciences, , Medicine, Health Sciences<​br>​
 +<​b>​DOI:​ </​b><​a href="​http://​www.ajnr.org/​content/​early/​2020/​05/​28/​ajnr.A6609">​http://​www.ajnr.org/​content/​early/​2020/​05/​28/​ajnr.A6609</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +Miller Fisher syndrome, also known as Miller Fisher variant of Guillain-Barre syndrome, is an acute peripheral neuropathy that can develop after exposure to various viral, bacterial, and fungal pathogens. It is characterized by a triad of ophthalmoplegia,​ ataxia, and areflexia. Miller Fisher syndrome has recently been described in the clinical setting of the novel coronavirus disease 2019 (COVID-19) without accompanying imaging. In this case, we report the first presumptive case of COVID-19-associated Miller Fisher syndrome with MR imaging findings.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +----------------------------------------------------------------------<​br>​
 +<​b>​[531] Title: </​b>​Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).<​br><​br>​
 +<​b>​Altmetric Score: </​b>​0.5<​br>​
 +<​b>​Pub_Date:​ </​b>​2020-05-29<​br>​
 +<​b>​Publisher:​ </​b>​Dermatology and Therapy<​br>​
 +<​b>​Keywords:​ </​b>​Dermatology,​ biologics, covid-19, infection, pandemic, psoriasis, sars-cov-2, virus<​br>​
 +<​b>​DOI:​ </​b><​a href="​https://​link.springer.com/​article/​10.1007/​s13555-020-00394-8">​https://​link.springer.com/​article/​10.1007/​s13555-020-00394-8</​a><​br><​br>​
 +<​b>​Abstract:​ </b>
 +The outbreak of the novel coronavirus known as SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) causing COVID-19 was first reported in late December 2019. Many patients with psoriasis on biologic therapy have asked their medical providers about the effect of biologics on COVID-19. However, it is currently unknown how biologic therapy for psoriasis might impact patients with psoriasis and COVID-19. In this article, we report on the clinical course of two patients on biologic medication for psoriasis who developed COVID-19 and successfully recovered from SARS-CoV-2 infection. Both patients presented with fever and respiratory symptoms, but neither patient required hospitalization. While more research is needed, it is reassuring to know that successful recovery is possible after COVID-19 infection in patients on biologic therapy for psoriasis.<​br>​
 +----------------------------------------------------------------------<​br><​br>​
 +
 +</​html>​
oa_db/covid19_case_reports_abstracts_pg9.txt · Last modified: 2020/06/28 05:24 by bpwhite